Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study
Key facts
- Who runs it
- M.D. Anderson Cancer Center
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 2
- Started
- 26 Jan 2022
- Ended
- 27 Dec 2023
- Type of study
- Interventional
- Treatments tested
- Computed Tomography
- Indocyanine Green Solution
- Therapeutic Bronchoscopy
- Record updated
- 23 October 2024
- Why it stopped
- 0 ACTUAL Enrollment must have Overall Recruitment
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age 18-80 years
- Medically operable
- Undergoing pulmonary resection for either stage I non-small cell lung cancer (NSCLC) (undergoing segmentectomy) or metastatic disease to the lung
- Lesions < 2cm in longest diameter
- Lesions are located at least 1cm from the pleura
Who cannot take part
- Iodide allergy
- Serum creatinine > 2.0
- Pregnant
- Central lesions
Where in United States
- M D Anderson Cancer CenterHouston, United States
About the trial
What the trial wants to find out
This phase II trial studies the use of Ion robotic bronchoscope with a mobile computed tomography (CT) scanner to biopsy tumors and inject a fluorescent dye called indocyanine green to mark the tumor during surgery in patients with stage I non-small cell lung cancer or cancer that has spread to the lung (lung metastases). Sometimes small tumors or those that are not on the surface of the lung can be challenging to remove without making larger incisions. Injecting the dye, may help doctors see the tumor more easily, which may allow for smaller incisions and by being able to see the tumor, doctors may be better able to decide where to make the incisions in order to get all of the tumor out.
The group in the trial
- Device feasibility (bronchoscopy, CT, indocyanine green)Treatment being tested
During standard of care surgical resection, patients undergo robotic bronchoscopy and CT. Patients also receive indocyanine green via injection.
Treatment: Computed Tomography, Indocyanine Green Solution, and Therapeutic Bronchoscopy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Resection of Pulmonary Lesions Aided by Robotic Bronchoscopy With Cone CT and INdocyanin Green (REPLACING) Study
- Record updated
- 23 October 2024